Nader; Pfizer Didn't Lose with the Neurontin Fine - Lyrica Does the Same Thing
Kathleen
ca...@drcarolgoodheart.com, lPick...@cdc.gov, Durlan...@yale.edu,
Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, margaret...@hhs.fds.gov,
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@ct.gov, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@ct.gov, kur...@washpost.com, georg...@washpost.com,
p...@allegorypress.com, commissi...@po.state.ct.us,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@ct.gov,
randall...@usdoj.gov, Robert....@yale.edu, editor@greenwich-
post.com, harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, bmi...@newstimes.com, tr...@hotmail.com,
rast...@aol.com, billc...@gmail.com, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com
Subject: Nader; Pfizer Didn't Lose with the Neurontin Fine - Lyrica
Does the Same Thing
Date: Dec 28, 2010 12:46 PM
Ralph Nader on Pharma Phraud, below
======================================================
Pfizer Didn't Lose with the Neurontin Fine -
Lyrica Does the Same Thing.
I will now demonstrate the even bigger
crime Pfizer commits, related to this:
BACKGROUND:
PFIZER PATENTS FOR GABA ANALOGS:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=GABA&FIELD1=&co1=AND&TERM2=pfizer&FIELD2=ASNM&d=PTXT
STRUCTURE OF NEURONTIN:
http://en.wikipedia.org/wiki/Gabapentin
STRUCTIRE OF LYRICA:
http://www.pfizer.com/files/products/uspi_lyrica.pdf
STRUCTURE OF GABA:
http://www.edinformatics.com/biotechnology/gaba.htm
So, you see that ^^^ Pfizer did not
care about the Neurontin fine because
it is in their favor to not follow up on
what Lyme is, because there is a huge
class of people out there who don't know
FibroFemino is 90% of the time Lyme or
Pam3Cys/TLR2-
agonist induced immunosuppression:
http://www.actionlyme.org/101016.htm
http://www.actionlyme.org/FIBROLENNYCYTOKINO.htm
Fibro-Lenny ^^^ absolutely knows chronic
Lyme is real, and that the Chronic Fatigue,
fake "Fibro-anxiety" disease is a lie:
http://www.actionlyme.org/081030.htm
http://www.actionlyme.org/MUNCHAUSENS.htm
See Lenny's two different definitions, ^^ there.
Fibro-Femino is
http://www.actionlyme.org/081030.htm
a ^^ *TRAP* diagnosis, that no one should fall
for. *Refuse* the "pressure points" test.
Chronic Lyme is real, and even worse is
LYMErix-Disease, the disease caused by
OspA, and the activation of Epstein-Barr
(and then you have all sorts of
trouble, like cancer, MS, and so on...):
http://www.actionlyme.org/101016.htm
If there is ongoing, long term pain,
these people have a long term
*ongoing* *PROCESS,* which means
something is there, causing the
chronic irritation. Otherwise, the
complainer is simply a Rx drug addict
and there are many among us "Lymies,"
unfortunately.
I know a lot of them. They refuse to
help themselves cuz they love the likes of
the brain and the pain candy, like Oxycontin,
which is malpractice treatment of Lyme:
http://www.actionlyme.org/BUNNEY_YALE_BRAIN_DAMAGE.htm
Yale's Psych ^^^ Department Head claims
to be an expert on the brain damage
caused by this malpractice treatment of
a real brain disease:
"Medications for psychiatric disorders can be both the cause of
delirium and exacerbate or contribute to delirium from other
causes."- The American Psychiatric Association.
Typically in the case of chronic
Lyme, spirochetes love nerve root
ganglia:
http://www.ncbi.nlm.nih.gov/pubmed/10908149
And then we have the issue of
Pam3Cys-activated Latent Epstein-Barr
which is really this, Chronic Lyme/
Chronic Fatigue disease. Think of it
as either pre-MS, or *clinical* MS
(no oligoclonal bands in the CFS,
although they could be there:
http://www.actionlyme.org/MARTIN_NINDS_MS_CHRONIC_LYME.htm
Therefore, you can see how it is
not in Pfizer's interest to discover/
report about chronic Lyme or LYMErix
Disease:
http://www.actionlyme.org/101016.htm
or the results of chronic agonism of
TLR2 by spirochetes shedding Osps
http://www.actionlyme.org/BARBOURS_STEALTH_BOMBERS.htm
because people are too stupid to know
that Lyrica is simply the next Neurontin.
It is not in Pfizer's interest to get
involved in Lyme crimes or TLR2 agonism
http://www.actionlyme.org/101016.htm
because there are plenty of druggies,
and there are plenty of Lyme Activism
antagonists [Pat Smith's group, who
reveal their techniques of harassment
of other Lyme activists very well, here:
http://www.actionlyme.org/LYME_SEX.htm
(Notice how I ^^^ played that chick.)]
There are plenty of stupid people out
there who inadvertently sell Pfizer's
drugs for them. ILADS.org, the
http://www.lymediseaseassociation.org
And all the Fibro-Femino groups who insist
they know what they're talking about and
do not want to hear about the fraudulent
testing for Lyme, like this one:
http://www.ct-cfids-fm.org/
So, you have to know what you're talking
about when you talk about corporate chemical
crime. Pfizer don't gotta do nothin or
say nothin, because all these so-called
"activist" beeches and tards like ILADS.org
are doing their work for them, selling
their non-cures and malpractice treatments.
KMDickson
http://www.actionlyme.org
=====================================================
http://www.commondreams.org/view/2010/12/28-3
Published on Tuesday, December 28, 2010 by CommonDreams.org
Pharmaceutical Industry Fraud
by Ralph Nader
The corporate defrauding of taxpayers (eg. Medicaid and Medicare) and
prescription drugs with skyrocketing prices was the subject of a
report by Public Citizen's Dr. Sidney Wolfe and his associates (see
citizen.org).
Dr. Wolfe's team compiled a total of 165 federal and state settlements
since 1991 totaling $19.8 billion in penalties. A key finding is that
the drug industry's penalties under the Federal False Claims Act
exceed even those assessed against the overcharging defense industry
for fraud.
Before we become overly impressed with the cumulative amount of the
penalties, specialists in corporate crime law enforcement believe that
adding more federal cops on the corporate crime beat, backed by a
determined law and order Justice Department with White House backing,
would have greatly increased the number of cases and imposition of
penalties on these drug industry giants.
Nonetheless, Dr. Wolfe's study shows that the pace of penalties has
picked up over the past five years. This is due to "a combination of
increased violations by companies and increased law enforcement on the
part of federal and state governments," says the report.
Many of these cases were initiated by company whistleblowers, who
under the False Claims Act can receive a share of the settlements.
Since the corporate bosses of these drug firms are almost never
prosecuted, what these executives fear the most are company employees
who go public with the evidence of corporate misdeeds.
These violations do more than financial damage to consumers and
government health insurance programs. One of the worst violations
involves companies promoting unproven, often dangerous uses for their
medicines. Last year, Pfizer paid $1.2 billion for illegal off-label
promotion -- the largest criminal fine in U.S.history. Other major
corporate violators were GlaxoSmithKline, Eli Lilly, Schering-Plough,
Bristol-Myers Squibb, AstraZeneca, TAP Pharmaceutical, Merck, Serono,
Purdue, Allergan, Novartis, Cephalon, Johnson & Johnson, Forest
Laboratories, Sanofi-aventis, Bayer, Mylan, Teva and King
Pharmaceuticals.
The violations by these and other drug companies point to the wide
range of impacts, including taking many lives of patients, which stems
from these recurrent activities. These criminal or civil illegalities
cover (1) overcharging government health programs, (2) unlawful
promotion, (3) monopoly practices, (4) kickbacks, (5) concealing study
findings, (6) poor manufacturing practices, (7) environmental
violations, (8) financial violations and (9) illegal distribution.
Outside the purview of the Public Citizen study are the ravages of
counterfeit drugs and poorly inspected ingredients in drugs, now
mostly coming from China and India, due to the outsourcing by U.S. and
European drug companies in their thirst for even greater profits.
Drug company sales are huge, growing from $40 billion in 1990 to $234
billion in 2008, and far exceeding inflation with their annual price
gouging. To make matters worse, in 2003, the Congressional
Republicans, with decisive support from some Democrats, passed the
drug benefit bill which explicitly prohibited Uncle Sam, the payer,
from bargaining for volume discounts with drug companies.
With over 400 full-time drug company lobbyists putting pressure on
Congress, and tens of millions of dollars flowing into the
legislators' campaign coffers, budgets for federal investigators,
prosecutors and inspectors are kept to a minimum. Unfortunately, crime
in the suites pays over and over again, despite occasional penalties.
A bright spot is the increasing enforcement action at the state level.
By last year, 32 states had enacted false claims acts, including
fourteen states that qualified as strong laws by federal standards.
Still, the Wolfe report concludes that the "current system of
enforcement is not working." He gives the examples of the $7.44
billion in financial penalties assessed over the past twenty years on
GlaxoSmithKline and Pfizer, as compared to their combined total of
$16.5 billion in global net profits in one year alone.
What would deter these illegal practices and risks to public safety?
Dr. Wolfe says "the lack of criminal prosecution that would result in
jailing of company executives." is key. Moreover, the report notes
that "a felony conviction could result in their companies becoming
ineligible for reimbursement from federal and state health programs, a
critical source of pharmaceutical company revenues."
A flicker of hope that a little change is on the way came from the
Food and Drug Administration's Deputy Chief Counsel for Litigation,
Eric Blumberg. He indicated that the government is considering going
after drug company executives for violations such as off-label
promotions. He stated: "unless the government shows more resolve to
criminally charge individuals -- at all levels in the corporate
hierarchy -- we can not expect to make progress in deterring off-label
promotion."
The problem is that the final operating decision is in the hands of
the Justice Department -- historically short-staffed and short-willed
to entreaties for prosecution by the FDA and other regulatory
agencies.
Furthermore, for over 30 years, the Justice Department has stone-
walled requests that it start a corporate crime database as it has
done with street crimes. Congress likes it this way, as it continues
to cash corporate campaign checks.
Just last week, however, outgoing Judiciary Committee Chairman,
Democrat John Conyers introduced a bill (H.R. 6545) to create such a
corporate crime data base in the Justice Department. Well, as the
saying goes, everything starts with a gesture!
Ralph Nader is a consumer advocate, lawyer, and author. His most
recent book - and first novel - is, Only The Super-Rich Can Save Us.
His most recent work of non-fiction is The Seventeen Traditions.
KMDickson
Dr. Vincent Quin, Ph.D.
Sir, would you please summarize this into a more readable 2 or 3 sentences.
hey how bout da bears!
willshak
>
> Sir, would you please summarize this into a more readable 2 or 3
> sentences.
>
> hey how bout da bears!
Why did you include the whole message and tell her to summarize?
>
>
> Kathleen wrote:
--
Bill
In Hamptonburgh, NY
In the original Orange County. Est. 1683
To email, remove the double zeroes after @
Dr. Vincent Quin, Ph.D.
> Dr. Vincent Quin, Ph.D. wrote the following:
>
>>
>> Sir, would you please summarize this into a more readable 2 or 3
>> sentences.
>>
>> hey how bout da bears!
>
>
> Why did you include the whole message and tell her to summarize?
>
>>
>>
>> Kathleen wrote:
>
>
>
hey how bout da bears
;-)